About Artrya
Artrya is an AI-driven healthcare company focused on transforming cardiovascular care through advanced diagnostic technology. The company partners with clinics and emergency departments to deliver new models of care for patients presenting with chest pain. Artrya's flagship product, Salix, uses artificial intelligence to analyze coronary computed tomography angiography (CCTA) scans, providing rapid insights into the type and volume of arterial plaque to facilitate accurate risk stratification of coronary artery disease patients within minutes. The company's mission centers on preventing the 600,000 American lives lost annually to undiagnosed coronary disease. Artrya's technology enables physicians to make evidence-based decisions about patient discharge, admission, and treatment pathways, moving away from the costly "just to be sure" approach that leads to over-testing. The AI-supported analysis helps quickly identify patients with minimal coronary artery disease who can be safely discharged, while catching early warning signs in at-risk patients who warrant further investigation. Artrya's solution addresses significant healthcare system inefficiencies, including the $10-13 billion spent annually on over-testing chest pain patients and the unnecessary admission of up to 90% of chest pain patients to emergency departments. The company is publicly listed on the Australian Securities Exchange and has received regulatory clearances in Australia and the United States. Artrya is headquartered in West Perth, Australia, and serves health systems, emergency departments, and primary care providers focused on improving cardiovascular care delivery and patient outcomes.
Mission & Story
Mission
We see a world where communities do not have to be plagued by a high rate of heart attack.
Clinical Focus
Medical conditions and clinical areas addressed by Artrya.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance for Salix Central USA product (K243038), Australian regulatory approval, company growth by factor of 10 as mentioned in employee testimonials
Key Partnerships
Company Details
- Headquarters
- West Perth, Western Australia, Australia
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 64 →
AccurKardia
AI-powered platform for cardiovascular disease detection and cardiac risk assessment.
Acorai
AI platform for cardiovascular disease detection and cardiac risk assessment.
Aisap
11-50 employees
AISAP provides FDA-cleared AI-powered diagnostic algorithms embedded in an operating system for point-of-care ultrasound (POCUS) devices. The platform enables rapid, expert-level cardiac imaging interpretation at the bedside, helping physicians detect structural heart disease early and make faster clinical decisions across hospitals, clinics, and screening programs.
AliveCor
AliveCor develops FDA-cleared, AI-powered ECG devices and software platforms for cardiac monitoring. The company offers portable ECG solutions ranging from consumer personal devices to clinical-grade 12-lead systems, serving patients, healthcare providers, biopharma companies, and health systems with remote and connected cardiac care.
Anumana AI
series c · 175 employees
Anumana AI develops and delivers AI-driven ECG algorithms to enable early diagnosis and intervention for cardiovascular conditions.
Bay Labs
Bay Labs is a health AI company focused on cardiology and cardiovascular health. The company's website is currently under construction with limited public information available.
BunkerHill Health
Bunkerhill Health provides Carebricks, an AI-powered platform that enables health systems to design, deploy, and operationalize AI agents across clinical and operational workflows. The platform reasons across patient data and automates actions within existing EHR systems.
Caption Health, Inc
Caption Health develops AI-powered ultrasound guidance technology that enables healthcare providers to capture high-quality cardiac ultrasound images, expanding access to diagnostic imaging beyond traditional specialists.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.